This article provides a detailed comparative analysis of two leading tools for differential exon usage and alternative splicing: DEXSeq and rMATS.
This comprehensive guide provides researchers, scientists, and bioinformaticians in drug development with a complete protocol for conducting differential exon usage analysis using DEXSeq.
This comprehensive guide provides researchers, scientists, and drug development professionals with a complete DESeq2 workflow for RNA-seq differential expression analysis.
This comprehensive guide provides researchers and bioinformaticians with a detailed, up-to-date comparison of the three leading statistical methods for RNA-seq differential expression analysis: DESeq2, edgeR, and limma-voom.
This article provides a comprehensive comparative analysis of network-based and odds ratio (OR) methods for predicting the pathogenicity of Variants of Uncertain Significance (VUS).
This article provides a detailed comparative analysis of Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS) for the detection and interpretation of Variants of Uncertain Significance (VUS).
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on utilizing the ClinVar database to identify, analyze, and resolve discrepancies in genetic variant interpretations.
This article provides a comprehensive guide to the functional specifications of ClinGen Variant Curation Expert Panels (VCEPs), critical components in translating genomic data into clinically actionable knowledge.
This comprehensive guide provides researchers, scientists, and drug development professionals with an in-depth exploration of the ClinGen Sequence Variant Interpretation (SVI) Functional Assay Documentation Worksheet.
This article provides a comprehensive analysis of the challenges associated with Variants of Uncertain Significance (VUS) in clinical Whole Exome Sequencing (WES).